Back to normal: super-response to mavacamten in a patient with obstructive hypertrophic cardiomyopathy
The International Journal of Cardiovascular Imaging · 2025
DOI: 10.1007/s10554-025-03452-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift The International Journal of Cardiovascular Imaging, 2025. Verfasst von Tobia Albertini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Stadtspital Zürich, Zurich, Switzerland. tobia.albertini@gmail.com. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Ventricular Outflow Obstruction, Cardiomyopathy, Hypertrophic, Ventricular Function, Left. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder characterized by left ventricular hypertrophy, often leading to left ventricular outflow tract (LVOT) obstruction and secondary mitral regurgitation (MR) due to systolic anterior motion (SAM) of the mitral valve leaflets. Mavacamten, a cardiac myosin inhibitor, is a modern treatment option aimed at reducing myocardial contractility, SAM and LVOT obstruction. We present the case of a patient with HCM responding not only with a marked reduction in LVOT obstruction and mitral regurgitation, but also with normalization of left ventricular (LV) mass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Stadtspital Zürich, Zurich, Switzerland. tobia.albertini@gmail.com.
- Cardiology Resident, Stadtspital Zürich, Zürich, Switzerland. tobia.albertini@gmail.com.
- Department of Cardiology, Stadtspital Zürich, Zurich, Switzerland.
- Institute for Radiology and Nuclear Medicine, Stadtspital Zürich, Zurich, Switzerland.
Zitieren
APA
Albertini, T., Bernheim, A. M., & Bruengger, A. A. S. (2025). Back to normal: super-response to mavacamten in a patient with obstructive hypertrophic cardiomyopathy. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-025-03452-4
Vancouver
Albertini T, Bernheim AM, Bruengger AAS. Back to normal: super-response to mavacamten in a patient with obstructive hypertrophic cardiomyopathy. The International Journal of Cardiovascular Imaging. 2025. doi:10.1007/s10554-025-03452-4
BibTeX
@article{Albertini2025,
author = {Albertini, Tobia and Bernheim, Alain M and Bruengger, Annina A Studer},
title = {Back to normal: super-response to mavacamten in a patient with obstructive hypertrophic cardiomyopathy},
journal = {The International Journal of Cardiovascular Imaging},
year = {2025},
doi = {10.1007/s10554-025-03452-4}
}
EUVIMED